iTeos Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. iTeos Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 95% to $12,595,000. The net income dropped to -$112,642,000 and profit margin reached -894%. Total operating expenses were $163,696,000.
Profit Margin
| 2018 | 0 | -18.05M | |
|---|---|---|---|
| 2019 | 0 | -22.45M | |
| 2020 | 0 | -38.03M | |
| 2021 | 344.77M | 214.52M | 62.22% |
| 2022 | 267.63M | 96.65M | 36.11% |
| 2023 | 12.59M | -112.64M | -894.34% |
ITOS Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 12.59M | 267.63M | 344.77M | 0 | 0 | 0 |
Cost of revenue | 898K | 813K | 615K | 535K | 611K | 0 |
Gross profit | 11.69M | 266.81M | 344.16M | -535K | -611K | 0 |
Operating exp. | ||||||
Research and development | 113.3M | 97.35M | 59.36M | 29.9M | 19.21M | 17.18M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 163.69M | 138.04M | 89.69M | 39.30M | 23.26M | 17.81M |
Operating income | -151.10M | 126.32M | 244.90M | -45.24M | -28.04M | -21.50M |
Other income (expenses), net | 42.07M | 22.41M | 11.56M | 7.15M | 5.71M | -163K |
Income before tax | -109.03M | 148.73M | 256.46M | -38.09M | -22.33M | -18.04M |
Income tax expense | 3.61M | 52.08M | 41.94M | -57K | 119K | 11K |
Net income | -112.64M | 96.65M | 214.52M | -38.03M | -22.45M | -18.05M |
Earnings per share | ||||||
Basic EPS | -3.15 | 2.72 | 6.1 | -1.09 | -0.64 | -2.4 |
Diluted EPS | -3.15 | 2.56 | 5.68 | -1.09 | -0.64 | -2.4 |
| Data source | Data source | Data source | Data source |